BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28876456)

  • 1. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
    Oba A; Mise Y; Ito H; Hiratsuka M; Inoue Y; Ishizawa T; Arita J; Matsueda K; Takahashi Y; Saiura A
    HPB (Oxford); 2018 Aug; 20(8):708-714. PubMed ID: 29534862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
    Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
    Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
    HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.
    Ferrero A; Langella S; Russolillo N; Vigano' L; Lo Tesoriere R; Capussotti L
    J Gastrointest Surg; 2012 Apr; 16(4):806-14. PubMed ID: 22258869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
    Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
    Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
    Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
    Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.
    Uchiyama K; Ueno M; Ozawa S; Kiriyama S; Shigekawa Y; Yamaue H
    World J Surg; 2010 Dec; 34(12):2953-9. PubMed ID: 20734045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection.
    Araki K; Harimoto N; Muranushi R; Hoshino K; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Shirabe K
    J Med Invest; 2019; 66(3.4):319-323. PubMed ID: 31656297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis.
    Schulz A; Dormagen JB; Drolsum A; Bjørnbeth BA; Labori KJ; Kløw NE
    Acta Radiol; 2012 Dec; 53(10):1081-7. PubMed ID: 23081954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.
    Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE
    HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?
    Leen E; Ceccotti P; Moug SJ; Glen P; MacQuarrie J; Angerson WJ; Albrecht T; Hohmann J; Oldenburg A; Ritz JP; Horgan PG
    Ann Surg; 2006 Feb; 243(2):236-40. PubMed ID: 16432357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation.
    Loss M; Schneider J; Uller W; Wiggermann P; Scherer MN; Jung W; Schlitt HJ; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2012; 50(1-2):65-77. PubMed ID: 22538536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.
    Nomura K; Kadoya M; Ueda K; Fujinaga Y; Miwa S; Miyagawa S
    J Clin Gastroenterol; 2007 Sep; 41(8):789-95. PubMed ID: 17700429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.